Laboratory Corporation of America Holdings
Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients
Last updated:
Abstract:
The present invention relates generally to methods of accurately quantifying HER2 and/or p95 expression in subjects with a HER2 positive cancer and indicating the risk of brain relapse in such patients.
Status:
Application
Type:
Utility
Filling date:
22 Oct 2018
Issue date:
22 Aug 2019